ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

“Flat” Administrative Structure To Include Resource Teams

September 15, 1995

Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 12, 1974

Fisher and Redmond Subject Of Misconduct Investigation; ORI

May 6, 1994

Obituary: Piotr Kulesza, 46, Pathologist At Northwestern, ECOG-ACRIN, Dies in Fall After Group Meeting

November 22, 2013

NCI Advisory Group, Other Cancer Meetings

January 30, 1976